Clinical Characteristics of Severe Congenital Neutropenia Caused by Novel ELANE Gene Mutations

Abstract

SCN cases were identified for the first time in China, and all patients carried novel ELANE mutations. Granulocyte-colony stimulating factor (G-CSF) was an effective treatment for most of the SCN patients and prevented life-threatening bacterial infections.